Type VI glycogen storage disease is due to the deficiency of –
**Core Concept:** Type VI glycogen storage disease is a rare autosomal recessive disorder characterized by glycogen accumulation in the liver, leading to impaired glucose production and increased susceptibility to hypoglycemia. It is caused by deficiencies in enzymes involved in glycogen degradation and is classified as a glycogen synthase deficiency.
**Why the Correct Answer is Right:** Type VI glycogen storage disease is caused by a deficiency of liver glycogen phosphorylase. Liver glycogen phosphorylase plays a crucial role in glycogen degradation, specifically in breaking down glycogen into glucose-1-phosphate. This process is essential for maintaining glucose levels in the bloodstream, which prevents hypoglycemia. In individuals with Type VI glycogen storage disease, the deficiency of liver glycogen phosphorylase leads to impaired glucose production and increased susceptibility to hypoglycemia.
**Why Each Wrong Option is Incorrect:**
A. Liver glycogen phosphorylase deficiency is the correct answer for Type VI glycogen storage disease, but this option is incorrect because it is not the correct name for the enzyme deficient in this disease.
B. Liver glucagon deficiency is incorrect because glucagon is a hormone that stimulates glycogenolysis (degradation of glycogen) but does not directly affect the enzyme deficiency in Type VI glycogen storage disease.
C. Liver glycogen synthase deficiency is incorrect because glycogen synthase is involved in glycogen synthesis, not degradation, and does not cause the clinical manifestations of Type VI glycogen storage disease.
D. Liver glucose-6-phosphatase deficiency is incorrect because glucose-6-phosphatase is involved in the final step of gluconeogenesis, not glycogen degradation, and does not cause the clinical manifestations of Type VI glycogen storage disease.
**Clinical Pearl:** Type VI glycogen storage disease is essential to differentiate from other types of glycogen storage diseases, as the clinical manifestations and treatment strategies differ significantly. It is crucial for healthcare professionals to understand the specific enzyme deficiency in each type of glycogen storage disease.